Biotech firm heads to Winchester Works space
Artizan’s move from nearby New Haven space slated for fall
A New Haven-based biotechnology company has signed a lease for space in the Winchester Works life sciences building in the city's Science Park section.
Officials at Artizan Biosciences announced the lease of 10,000 square feet of space on Tuesday. The company is focused on developing treatments for inflammatory diseases of the human digestive tract.
A spokeswoman for Artizan Biosciences said the lease the company signed is for seven years, with an option to expand the amount of space after five years.
The lease with Artizan Biosciences bring the amount of occupied space in Winchester Works to 93,000 square feet. The building has 140,000 square feet of space and last week, the Westchester County, N.Y., developer that is making over the former arms factory announced plans to build three smaller laboratory and office spaces on speculation.
“Companies like Artizan Biosciences play a critical role in advancing lifechanging research and development and Winchester Works has been specifically designed to support these needs,” said Jake Pine, senior director with LMXD. “The Science Park campus not only offers direct access to local talent and the region's top institutions but also provides tenants with the worldclass lab and office space they need to be successful.”
Artizan Biosciences currently operates out 5,000 square feet of space at 25 Science Park, which is a short distance away from Winchester Works. The company expects to move into its new lab and office space this fall, according to Dr. Bridget Martell, Artizan's president and chief executive officer.
“As we continue to grow our staff and expand our clinical efforts, moving to Winchester Works allows us to accelerate our research efforts,” Martell said. “We're excited to remain in the burgeoning life sciences community of New Haven and close to the company's beginnings at Yale University.”
Artizan currently has 18 employees and is looking to hire more as it expands into its new home, she said. The additional space and the new employees will allow the company to continue advancing its lead product candidate, ARZC-001, a treatment for inflammatory bowel disease.
In addition to ARZC-001, Artizan is advancing additional late preclinical stage drug candidates for inflammatory bowel disease and a Parkinson's disease therapeutic discovery and development program.
Winchester Works is part of the redevelopment of the former Winchester Arms complex, which is located in the city's Prospect Hill neighborhood. The building is the first stage of the Winchester Center master plan, a multi-phase redevelopment concept that encompasses the four remaining buildings in the complex as well as the development of four other sites in Yale's nearby Science Park.
The plan calls for as many as 1,000 apartments, retail space, and 500,000 square feet of office and lab space.